National Bank of Canada’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-145
Closed -$1.63K 2960
2025
Q2
$1.63K Buy
145
+4
+3% +$37 ﹤0.01% 2642
2025
Q1
$1.33K Sell
141
-140
-50% -$1.41K ﹤0.01% 2550
2024
Q4
$3.16K Buy
+281
New +$4.94K ﹤0.01% 2516

Other funds holding EVH

National Bank of Canada's EVH Position: Q3 2025 in Review

National Bank of Canada sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 145 shares — an estimated $1.63K sold.

National Bank of Canada first reported a position in EVH in Q4 2024 and held it in 3 quarters. The position peaked at $3.16K in Q4 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • National Bank of Canada reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 145 Evolent Health shares in Q3 2025, an estimated $1.63K.
  • National Bank of Canada first reported a position in Evolent Health in Q4 2024 and held it in 3 quarters.
  • National Bank of Canada's Evolent Health position peaked at $3.16K in Q4 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.